Danish National Research Foundation Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00975962
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Danish National Research Foundation

Active Ingredients

Drugs in Phase 4 Trials (2)

bacille calmette-guerin (1 trial)

doxycycline (vibramycin) (1 trial)

Drugs in Phase 3 Trials (1)

alteplase (Activase) (1 trial)

Drugs in Other Trials (1)

capsaicin (qutenza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4